Cybin (OTCMKTS:CLXPF) Hits New 1-Year High – What’s Next?

Cybin Inc. (OTCMKTS:CLXPFGet Free Report)’s share price reached a new 52-week high during trading on Thursday . The stock traded as high as $11.52 and last traded at $11.40, with a volume of 395431 shares changing hands. The stock had previously closed at $9.94.

Cybin Trading Up 14.7 %

The firm’s fifty day moving average price is $6.79 and its 200 day moving average price is $2.57. The firm has a market capitalization of $1.69 billion and a PE ratio of -41.42.

Cybin Company Profile

(Get Free Report)

Cybin Inc, a life sciences company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Natures Journey. The Serenity Life segment engages in the research and development of pharmaceutical and nutraceutical psilocybin products.

Recommended Stories

Receive News & Ratings for Cybin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cybin and related companies with MarketBeat.com's FREE daily email newsletter.